Skip to content

Ibex Medical Analytics

HealthTech & Life Sciences

Ibex Medical Analytics develops AI-assisted pathology software for reviewing digitised tissue slides.

Introduce me to Ibex Medical Analytics
Ibex Medical Analytics website sharing image

Image source: company website sharing image

Founders & company facts

Sources reviewed:

Reported cumulative funding

$116,600,000 · Source

This index includes companies with publicly reported total funding up to US$150 million. This is a reported total, not valuation, the latest round size or confirmation of an open round. Funding reviewed: .

Documented founding team

Founded
2016Source
Reported Israeli location
Tel Aviv-YafoSource
Team range in directory
51-200Source
Reported business model
B2BSource

Selected disclosed financing

Selected transactions, with dates, funding types and reported participants.

  1. Sept 2023$55MSeries C
    Named participants

    83North · Sienna Venture Capital · aMoon Fund · Planven Entrepreneur Ventures · Dell Technologies Capital · Octopus Ventures

    Source
  2. Nov 2022$10MUnspecified round
    Named participants

    Kreos Capital

    Source

Company overview

Product & customers

Ibex Medical Analytics develops AI-assisted pathology software for reviewing digitised tissue slides. Its platform supports pathologists in identifying cancer-related and other diagnostic features, and the company also describes applications in biomarker research and drug development.

Commercial potential · editorial analysis

Pathology digitisation creates an opening for software that assists repetitive review and quality assurance. Multiple tissue types and research uses may broaden demand, provided the product fits laboratory routines and delivers dependable clinical support.

What to validate

Review evidence by tissue type, authorisation scope and performance on external datasets. Scanner compatibility, false findings, clinician acceptance and the cost of implementation are necessary to understand how technical capability becomes recurring revenue.

Product source reviewed on . Company source